HomePOLB • LON
add
Poolbeg Pharma PLC
Previous close
GBX 3.50
Day range
GBX 3.40 - GBX 3.80
Year range
GBX 2.25 - GBX 14.30
Market cap
17.00M GBP
Avg Volume
2.87M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
(GBP) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.79M | 37.61% |
Net income | -1.77M | -66.60% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.74M | -34.40% |
Effective tax rate | 3.52% | — |
Balance Sheet
Total assets
Total liabilities
(GBP) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 7.82M | -35.72% |
Total assets | 10.25M | -33.58% |
Total liabilities | 974.00K | -1.22% |
Total equity | 9.27M | — |
Shares outstanding | 500.00M | — |
Price to book | 1.75 | — |
Return on assets | -43.70% | — |
Return on capital | -48.29% | — |
Cash Flow
Net change in cash
(GBP) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -1.77M | -66.60% |
Cash from operations | -1.19M | -13.63% |
Cash from investing | 73.50K | -1.34% |
Cash from financing | — | — |
Net change in cash | -1.12M | -14.78% |
Free cash flow | -908.38K | -5.39% |
About
Founded
2021
Website
Employees
16